🇺🇸 FDA
Patent

US 9051567

Methods for increasing efficacy of lipid formulated siRNA

granted A61KA61K31/366A61K31/567

Quick answer

US patent 9051567 (Methods for increasing efficacy of lipid formulated siRNA) held by Tekmira Pharmaceuticals Corporation expires Mon Jun 04 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Tekmira Pharmaceuticals Corporation
Grant date
Tue Jun 09 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 04 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
25
CPC classes
A61K, A61K31/366, A61K31/567, A61K31/7088, A61K9/127